• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

阿芬太尼在烧伤患者中的处置情况。

Disposition of alfentanil in burns patients.

作者信息

Macfie A G, Magides A D, Reilly C S

机构信息

Department of Anaesthesia, University of Sheffield.

出版信息

Br J Anaesth. 1992 Nov;69(5):447-50. doi: 10.1093/bja/69.5.447.

DOI:10.1093/bja/69.5.447
PMID:1467073
Abstract

We have studied the disposition of alfentanil in six patients (who had suffered 10-30% surface area burns 5-21 days previously) undergoing surgical debridement and grafting and compared the data with those from a control group of six patients matched for age, sex and weight undergoing body surface surgery of similar duration. Plasma samples were collected up to 480 min after an i.v. bolus of alfentanil 50 micrograms kg-1. Drug concentrations were measured by radioimmunoassay and alfentanil binding to plasma proteins by equilibrium dialysis. The burns patients had significantly greater concentrations of alpha-1-acid glycoprotein (AAG) and smaller concentrations of albumin. The mean protein binding of alfentanil was 94.2 (SEM 0.05)% in the burns group and 90.7 (0.4)% in the control group (P = 0.004). There was a good correlation between AAG concentration and protein binding (r = 0.8). The volume of distribution and total clearance of alfentanil were reduced significantly in the burns group. The clearance of the unbound fraction and the elimination half-life of alfentanil were not decreased significantly.

摘要

我们研究了6例患者(5 - 21天前体表烧伤面积达10 - 30%)在接受外科清创和植皮手术时阿芬太尼的处置情况,并将数据与6例年龄、性别和体重匹配、接受类似时长体表手术的对照组患者的数据进行了比较。静脉注射50微克/千克阿芬太尼后,在长达480分钟的时间内采集血浆样本。通过放射免疫分析法测定药物浓度,通过平衡透析法测定阿芬太尼与血浆蛋白的结合情况。烧伤患者的α1 - 酸性糖蛋白(AAG)浓度显著更高,白蛋白浓度更低。烧伤组阿芬太尼的平均蛋白结合率为94.2(标准误0.05)%,对照组为90.7(0.4)%(P = 0.004)。AAG浓度与蛋白结合之间存在良好的相关性(r = 0.8)。烧伤组阿芬太尼的分布容积和总清除率显著降低。阿芬太尼游离部分的清除率和消除半衰期没有显著降低。

相似文献

1
Disposition of alfentanil in burns patients.阿芬太尼在烧伤患者中的处置情况。
Br J Anaesth. 1992 Nov;69(5):447-50. doi: 10.1093/bja/69.5.447.
2
Influence of Crohn's disease on the pharmacokinetics and pharmacodynamics of alfentanil.克罗恩病对阿芬太尼药代动力学和药效学的影响。
Br J Anaesth. 1993 Dec;71(6):827-34. doi: 10.1093/bja/71.6.827.
3
Plasma concentration and protein binding of alfentanil during high-dose infusion for cardiac surgery.心脏手术大剂量输注期间阿芬太尼的血浆浓度与蛋白结合率
Br J Anaesth. 1994 May;72(5):571-6. doi: 10.1093/bja/72.5.571.
4
Pharmacokinetics of alfentanil in chronic renal failure.阿芬太尼在慢性肾衰竭中的药代动力学。
Anesth Analg. 1987 Jan;66(1):53-6.
5
Disposition of alfentanil in patients receiving a renal transplant.接受肾移植患者中阿芬太尼的处置情况。
J Pharm Pharmacol. 1989 Sep;41(9):654-7. doi: 10.1111/j.2042-7158.1989.tb06553.x.
6
Binding of alfentanil to human alpha 1-acid glycoprotein, albumin and serum.阿芬太尼与人α1-酸性糖蛋白、白蛋白及血清的结合。
Int J Clin Pharmacol Ther Toxicol. 1991 Mar;29(3):96-102.
7
Alfentanil pharmacokinetics in patients with cirrhosis.肝硬化患者中阿芬太尼的药代动力学
Anesthesiology. 1985 Apr;62(4):480-4. doi: 10.1097/00000542-198504000-00018.
8
[Effect of duration of infusion on elimination rate of alfentanil].[输注持续时间对阿芬太尼消除率的影响]
Anaesthesiol Reanim. 1995;20(4):97-100.
9
Effects of different hepatic pathologies on disposition of alfentanil in anaesthetized patients.不同肝脏病理状态对麻醉患者中阿芬太尼处置的影响。
Br J Anaesth. 1992 May;68(5):462-5. doi: 10.1093/bja/68.5.462.
10
Alfentanil pharmacokinetics in patients undergoing abdominal aortic surgery.
Can J Anaesth. 1991 Jan;38(1):61-7. doi: 10.1007/BF03009165.

引用本文的文献

1
[Not Available].[无可用内容]。
Ann Burns Fire Disasters. 2008 Mar 31;21(1):38-42.
2
Tissue accumulation of cephalothin in burns: a comparative study by microdialysis of subcutaneous interstitial fluid cephalothin concentrations in burn patients and healthy volunteers.头孢噻吩在烧伤患者体内的组织蓄积:通过微透析法对烧伤患者和健康志愿者皮下组织间液中头孢噻吩浓度进行的对比研究。
Antimicrob Agents Chemother. 2009 Jan;53(1):210-5. doi: 10.1128/AAC.00718-08. Epub 2008 Oct 27.
3
Physiology-based simulations of a pathological condition: prediction of pharmacokinetics in patients with liver cirrhosis.
基于生理学的病理状况模拟:肝硬化患者药代动力学的预测
Clin Pharmacokinet. 2008;47(11):743-52. doi: 10.2165/00003088-200847110-00005.
4
Influence of burns on pharmacokinetics and pharmacodynamics of drugs used in the care of burn patients.烧伤对烧伤患者治疗中所用药物药代动力学和药效学的影响。
Clin Pharmacokinet. 2008;47(10):635-54. doi: 10.2165/00003088-200847100-00002.
5
Development and evaluation of a generic physiologically based pharmacokinetic model for children.儿童通用生理药代动力学模型的开发与评估
Clin Pharmacokinet. 2006;45(10):1013-34. doi: 10.2165/00003088-200645100-00005.
6
A mechanistic approach for the scaling of clearance in children.一种用于儿童清除率缩放的机制性方法。
Clin Pharmacokinet. 2006;45(7):683-704. doi: 10.2165/00003088-200645070-00004.
7
Drug interactions with patient-controlled analgesia.患者自控镇痛的药物相互作用。
Clin Pharmacokinet. 2002;41(1):31-57. doi: 10.2165/00003088-200241010-00004.
8
Pharmacokinetics and pharmacodynamics of sedatives and analgesics in the treatment of agitated critically ill patients.镇静剂和镇痛药在治疗躁动危重症患者中的药代动力学和药效学
Clin Pharmacokinet. 1997 Dec;33(6):426-53. doi: 10.2165/00003088-199733060-00003.
9
Measurement and analysis of unbound drug concentrations.游离药物浓度的测定与分析。
Clin Pharmacokinet. 1996 Jun;30(6):445-62. doi: 10.2165/00003088-199630060-00003.
10
Clinical pharmacokinetics in patients with burns.
Clin Pharmacokinet. 1995 Jul;29(1):15-28. doi: 10.2165/00003088-199529010-00003.